October 3 - 6, 2019   Chicago Marriott Downtown Magnificent Mile

Registration Information

Online registration is now closed.

Walk-in registrations are welcome starting at 8:00 a.m. on Thursday, October 3. You may also purchase lunch tickets tickets at the registration desk any time during the conference.

Advance registration is encouraged, as space and materials are limited. To qualify for the discounted registration fee, the completed form and payment must be received by the Lurie Cancer Center on or before August 31, 2019. The registration fee includes conference tuition, CME credits, printed and digital materials, four breakfasts, refreshment breaks and an evening reception. You must make separate hotel arrangements.

Registrants may check in for the conference on the 7th floor of the Chicago Marriott Downtown Magnificent Mile on Wednesday, October 2 from 6:00 p.m. - 8:00 p.m. or beginning at 8:00 a.m. on Thursday, October 3. Walk-in registrations are also welcome beginning at 8:00 a.m. on Thursday, October 3.


Type Early Bird
Through August 31
Starting September 1
General $575 $675
Fellow/Student/Trainee $275 $375
Nurse/Physician Assistant/Nurse Practitioner $275 $375
Industry Fee $775 $875


Lunch Ticket $25/day, no refunds

Digital Materials

Access to General Session Presentations Available

Registrants will be able to view and/or download general session PowerPoint presentations (with some exceptions) via the Lynn Sage Breast Cancer Symposium website the week before the symposium and view updated presentations during and after the live presentations. To access, you must log onto lynnsagebreastcancer.org as a registered participant at the Symposium. Check your e-mail for instructions.

Payment Information

You may pay your fees by credit card (Visa, Master Card, American Express, Discover, Diner's Club and JCB).

Refund/Cancellation Policy

Registration fees less a $50 administrative handling fee are refundable if a written request is received on or before September 12, 2019. Please include your registration ID number when requesting a refund. No refunds will be granted after September 12, 2019; however, you may transfer your registration to a colleague.

Special Assistance

In compliance with the Americans with Disabilities Act, Northwestern University will make all reasonable efforts to accommodate persons with disabilities at this meeting. Additionally, if you have any special dietary restrictions, please notify us prior to the symposium.


To submit requests or request further information contact the Lurie Cancer Center at 312.503.7809 or e-mail us at cancer@northwestern.edu.

Related Links

Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Lynn Sage Comprehensive Breast Surgical Center

Registration Desk

Maintenance of Certification (MOC)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 21.0 MOC points [and patient safety MOC credit] in the American Board of Internal Medicine's (ABIM) MOC program.

Accreditation Statement

The Northwestern University Feinberg School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Hour Statement

The Northwestern University Feinberg School of Medicine designates this live activity for a maximum of 21.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Credits

The American Academy of Nurse Practitioners and the American Nurses Credentialing Center accept AMA PRA Category 1 Credits(s)™ from organizations accredited by the ACCME.

Faculty Disclosure

Current guidelines state that participants in CME activities should be made aware of any affiliation of financial interest that may affect the speaker's presentation. Each speaker has been requested to complete a faculty disclosure form. The names of faculty members declaring a relationship or who will be discussing off-label usage will be indicated in the course syllabus. All faculty will be disclosing.

Educational Objectives

  1. Discuss the opportunities for risk reduction in women at increased risk for breast cancer
  2. Describe the role of histology and molecular profiling in determining breast cancer prognosis
  3. Identify prognostic factors and treatment options in DCIS
  4. Define current local and systemic approaches to the patient receiving neoadjuvant therapy
  5. Cite new chemotherapy and immunotherapy approaches to triple negative breast cancer
  6. Review the risks and benefits of de-escalating surgery, radiotherapy and systemic therapy for breast cancer management

Sponsored by

Feinberg School of Medicine

© 2018 Robert H. Lurie Comprehensive Cancer Center